Traws Pharma, Inc. (TRAW)
Traws Pharma Files Tivoxavir Marboxil Investigational New Drug (IND) Application for Influenza Therapy, and Provides Updated Results from the Ongoing Clinical Study of Ratutrelvir in PAXLOVID®-Eligible and Ineligible COVID-19 Patients
📈 **POSITIVE** • Medium confidence analysis (62%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (75%) **Content type:** Clinical